ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
EU approval for Palynziq in adult phenylketonuria
May 09, 2019The European Commission has approved BioMarin’s Palynziq (pegvaliase injection) for the treatment of phenylketonuria (PKU) in patients aged 16 years or older. -
EU approval for Palynziq in adult phenylketonuria
May 09, 2019The European Commission has approved BioMarin’s Palynziq (pegvaliase injection) for the treatment of phenylketonuria (PKU) in patients aged 16 years or older. -
FDA Approves Palynziq
May 31, 2018The U.S. Food and Drug Administration today approved Palynziq (pegvaliase-pqpz) for adults with a rare and serious genetic disease known as phenylketonuria (PKU). -
FDA approves Palynziq for PKU, a rare and serious genetic disease
May 29, 2018Novel enzyme therapy for adults with PKU who have uncontrolled blood phenylalanine concentrations with current treatment…
Pharma Sources Insight January 2025
